Found 49 matching trials
Primary Prevention of Thrombocytopenia Associated With T-DM1 Therapy in HER2 Positive Breast Cancer With Herombopag
NAAdo-trastuzumab emtansine (T-DM1) demonstrates favorable efficacy in breast...
Location
Multiple Locations
Study Impact on Outcome of Eltrombopag in Elderly Patients with Acute Myeloid Leukemia Receiving Induction Chemotherapy
PHASE2Phase II randomized placebo-controlled study to assess the impact on outcom...
Status
Active Not Recruiting
Location
CHU ANGERS - Maladies du sang
A PK Study to Assess the Drug-drug Interaction of a BCRP Inhibitor on Adagrasib
PHASE1A Phase 1, Open-label, One-sequence Crossover Study to Investigate the Effe...
Location
Fortrea Clinical Research Unit Daytona Beach (Labcorp Clinical Research Unit Daytona Beach)
Clinical Evaluation of SB-497115-GR in Chronic Idiopathic Thrombocytopenic Purpura (ITP)
PHASE3This is a Phase II/III multicenter study comprising of the double-blind, fo...
Location
GSK Investigational Site
A Rollover Study to Provide Continued Treatment With Eltrombopag
PHASE4The objective of this study was to provide continued treatment with eltromb...
Location
Novartis Investigative Site
A Study to Assess the Safety and Efficacy of Eltrombopag in Japanese Subjects With Refractory, Moderate or More Severe Aplastic Anemia
PHASE2This was a non-randomized, open-label, phase II study to assess the efficac...
Location
Novartis Investigative Site
Eltrombopag for Treatment of Fanconi Anemia
PHASE2An open-label, phase II study to assess the efficacy and safety of eltrombo...
Location
Hospital Infantil Universitario Niño Jesús (HIUNJ)
The Use of Eltrombopag Post HSCT in BMFD
PHASE2Bone marrow failure disease(BMFD) is a kind of bone marrow due to congenita...
Location
The First Affiliated Hospital of Soochow University
Safety and Efficacy of Eltrombopag at Escalated Doses
PHASE2Study rationale is based on the data that in previous clinical studies of e...
Location
Weill Cornell Medicine
Identification and Validation of Biomarkers for Breast Cancer Resistance Protein (BCRP)
PHASE1This is an open-label, non-randomized, fixed-sequence study. Subjects will ...